Ratings Bridgepoint Group plc

Equities

BPT

GB00BND88V85

Market Closed - London Stock Exchange Other stock markets 11:35:07 2023-12-07 am EST			5-day change	1st Jan Change
241.6 ^GBX	+0.17%		+6.71%	+26.76%

Dec. 04	Petrofac jumps despite free cash flow miss	AN
Dec. 04	Capita to sell Fera Sciences stake to Bridgepoint for GBP60 million	AN

Strengths

Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 59% by 2025.
Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
The company is in a robust financial situation considering its net cash and margin position.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts covering this company mostly recommend stock overweighting or purchase.
The opinion of analysts covering the stock has improved over the past four months.
Historically, the company has been releasing figures that are above expectations.

Weaknesses

The company's "enterprise value to sales" ratio is among the highest in the world.
Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector : Investment Management & Fund Operators

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
BRIDGEPOINT GROUP PLC	+26.76%	2 412 M $		C+
BLACKROCK, INC.	+5.19%	111 B $		A-
UBS GROUP AG	+42.81%	91 411 M $		C+
BROOKFIELD CORPORATION	+14.44%	55 559 M $	-	B+
APOLLO GLOBAL MANAGEMENT, INC.	+41.98%	51 403 M $		C
BANK OF NEW YORK MELLON CORPORATION (THE)	+6.39%	36 546 M $		C+
AMERIPRISE FINANCIAL, INC.	+13.28%	35 433 M $		A-
3I GROUP PLC	+72.64%	28 117 M $		A-
T. ROWE PRICE GROUP INC.	-8.36%	22 318 M $		B
STATE STREET CORPORATION	-5.66%	22 045 M $		A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes